Imprivata
-
sponsored content, Artificial Intelligence
How Cybersecurity Solutions are Helping Curb America’s Opioid Crisis
As healthcare organizations comply with the federal EPCS mandate, artificial intelligence and digital identity technologies should be utilized to detect, reduce, and remediate drug diversion.
-
Microsoft and Imprivata collaborate on cloud-based healthcare platform
The tech giant and the health IT security company have teamed up to develop an identity and access management cloud platform for the healthcare industry.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Comcast and Independence Health Group joint venture Quil Health names a CEO
Quil plans to launch its first pilot programs later this year, which looks to be step-by-step content guides to help people navigate specific healthcare journeys like a knee or hip replacement.
-
New Imprivata solution enables more secure access to clinical devices
Rather than manually entering their username and password every time they utilize a device, Imprivata Mobile Device Access lets clinicians tap their badge to a mobile device, then single sign-on into their applications.
-
Cyberattack affects hospitals and businesses worldwide
An enormous ransomware attack has impacted organizations across the globe, including the National Health Service. U.K. hospitals resorted to diverting patients and using pen and paper for documentation.
-
Imprivata CIO drives home cybersecurity risks for hospitals and what they can do to minimize them
Imprivata CIO Aaron Miri called attention to cybersecurity risks hospitals face and ways they can reduce medical errors with biometrics.
-
Docs at HealthEast seem to love e-prescribing for controlled drugs
Since HealthEast Care System in St. Paul, Minnesota, became the first health system in the state to go live with EPCS two years ago, clinicians have saved an aggregate of about 500 hours per month in time spent writing prescriptions for controlled drugs, CHIME attendees heard Wednesday.